Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Reiner-Link

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecules (Basel, Switzerland)|July 2, 2021
Biphenylalkoxyamine Derivatives-Histamine H<sub>3</sub> Receptor Ligands with Butyrylcholinesterase Inhibitory ActivityDorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Pharmaceutics|October 27, 2022
Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo EvaluationDorota Łażewska, Agata Siwek, Agnieszka Olejarz-Maciej, et al.
Bioorganic Chemistry|July 4, 2021
Cyanobiphenyls: Novel H<sub>3</sub> receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's diseaseJustyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Journal of Medicinal Chemistry|July 7, 2023
Dual Piperidine-Based Histamine H<sub>3</sub> and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic PainKatarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecules (Basel, Switzerland)|July 2, 2021
Biphenylalkoxyamine Derivatives-Histamine H<sub>3</sub> Receptor Ligands with Butyrylcholinesterase Inhibitory ActivityDorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Pharmaceutics|October 27, 2022
Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo EvaluationDorota Łażewska, Agata Siwek, Agnieszka Olejarz-Maciej, et al.
Bioorganic Chemistry|July 4, 2021
Cyanobiphenyls: Novel H<sub>3</sub> receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's diseaseJustyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Journal of Medicinal Chemistry|July 7, 2023
Dual Piperidine-Based Histamine H<sub>3</sub> and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic PainKatarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Pageof 2